99.85% Viral Load Reduction with REM plus Brilacidin

Discussion in 'Gilead Sciences' started by anonymous, Oct 5, 2020 at 7:31 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Remdesivir with Brilacidin combination resulted in a 99.85% Viral Load Reduction in a recent RBL testing. Wake up Gilead, Remdesivir alone isn't going to be sufficient enough! Innovation Pharmaceutical's Brilacidin looks to be the real deal, much better as a single agent vs. Remdesivir, different MOA's.
     

  2. anonymous

    anonymous Guest

  3. anonymous

    anonymous Guest

    Combo agent coming soon 2022
     
  4. anonymous

    anonymous Guest

  5. anonymous

    anonymous Guest

    Works